Back to Market返回行情

NVST Envista Holdings Corp

USHealthcare
$26.12+1.38%OpenMarket Cap: $4.25B

As of 2026-07-10 15:21

Why NVST matters now

Envista Holdings Corp (NVST) is a US stock in Healthcare. The latest InvestLog snapshot shows $26.12 with +1.38% on the session and $4.25B in market capitalization; recent performance reads 1-month +12.41% and YTD +19.35%.

The latest financial table shown here is Q1 2026, with revenue of $705.5M, net income of $38.7M, and EPS of $0.23. Investors can compare that operating picture with valuation signals such as P/E 88.48 and FCF yield 5.2%.

The latest indexable market news headline is "Does NVST Stock Still Deserve a Place in Your Portfolio?" from Zacks Investment Research.

Additional event context on this page matters because analyst consensus is Hold with a median target of $31.00; recent insider activity includes Keel Paul A filing F-InKind. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

88.48

PEG

0.85

P/B

1.38

P/S

1.50

EV/EBITDA

13.62

DCF Value

$48.64

FCF Yield

5.2%

Div Yield

0.0%

Margins & Returns

Gross Margin

55.1%

Operating Margin

9.0%

Net Margin

2.4%

ROE

2.2%

ROA

1.2%

ROIC

1.8%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$705.5M$38.7M$0.23
Q4 2025$750.6M$32.9M$0.20
FY 2025$2.72B$47.0M$0.28
Q3 2025$669.9M$-30.3M$-0.18

Analyst Ratings

Consensus

Hold

Target (Consensus)

$28.33

Target (Median)

$31.00

Target Range

$19.00 - $35.00

Strong Buy: 1Buy: 6Hold: 8Sell: 0Strong Sell: 0
BarclaysOverweight
2026-06-11
Evercore ISI GroupOutperform
2026-05-07
BairdOutperform
2026-05-07
JP MorganNeutral
2026-05-07
Morgan StanleyEqual Weight
2026-04-24

Trading Activity

Insider Trades

Keel Paul Adirector, officer: Chief Executive Officer
Sell2026-05-27
Huennekens R Scottdirector
Sell2026-05-21
Raskas Danieldirector
Sell2026-05-21
Pierce James Andrewdirector
Sell2026-05-21
GALLAHUE KIERANdirector
Sell2026-05-21

Company Info

Sector

Healthcare

Industry

Medical - Equipment & Services

Country

US

Exchange

Beta

0.89

Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.